摘要
目的 :为探讨急性上呼吸道感染 (简称上感 )合并心肌酶升高的临床意义、病程及预后。方法 :对 30例上感并心肌酶升高的患儿的临床资料进行总结分析。结果 :血清肌酸磷酸激酶同功酶(CK -MB)与肌酸磷酸激酶 (CK)之比值小于 6%的 2 6例患儿一周内症状消失 ,心肌酶恢复正常 ;4例CK -MB/CK大于 6%的患儿中有 1例心肌肌钙蛋白I(CTnI)为阳性 ,临床诊断为轻度心肌炎 ,1 3天后临床治愈 ;另外 3例合并心肌损伤的患儿 1 0天后临床治愈。结论 :上感合并心肌酶升高的患儿大多数并非心肌损害或心肌炎 ,而是由于高热及肌肉注射引起 ,预后良好。我们要根据临床症状及CK -MB/CK之比值来确诊心肌损伤 ,必要时可测定CTnI帮助诊断。
Objective: To approach the clinical meaning, course of disease and prognosis of acute upper respiratory infections (be called AURI) with myocardium enzyme rising.Method: Clinical datas were performed to summarize and to analyse on 30 cases AURI with myocardium enzyme rising. Result: Symptom disappeared in aweek of 26 cases with CK-MB/CK less than 6%,clinical diagnose slight myocarditis,clinical restore health after 13 days;other 3cases with myocardium damage,clinical restore health after 10 days. Conclusion: Patients of AURI with myocardium enzyme rising most be really not myocardium damage or myocarditis,but being lead to by fever and inject muscle,prognosis fine.We must according to the clinical symptom and ratio of CK-MB/CK to diagnose myocardium damage,may determine CTnI to help diagnosing in necessary time.
出处
《河北医学》
CAS
2004年第1期19-21,共3页
Hebei Medicine